QIAGEN Partners to Develop Novel Companion Diagnostic in Lung Cancer
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
Analytica - Hall A1, Stand 514
In vitro diagnostic approved to support use of Bristol-Myers Squibb’s OPDIVO® for non-squamous non-small cell lung cancer
Share your expertise and vote for the product that made most difference to your research in 2015
First truly end-to-end solution for next-generation sequencing receives Red Dot award
Discover SelectScience® video interviews and articles about the latest Alzheimer’s disease research methods
SelectScience® brought a grand piano to the Pittcon show floor for the first time ever
Analyzing 50-year old DNA from highly complex samples
The new technology speeds up in-database, large-scale analyses by a factor of approximately 400, helping to advance genomic medical research
Mr. Alpert is to provide support to UVM management on policy, budgets and strategic planning
TATAA Biocenter also to introduce Swift Biosciences’ NGS products in its popular NGS training courses
Maximizes CRISPR gene editing efficiency and lowers the risk of off-target effects
DeNovix Inc. launches the Ultra High Sensitivity dsDNA fluorescence quantification assay
Company to share latest advances at pathology congress
The SeqCap EZ DNA kit allows easy target enrichment, whilst avoiding human error